You are here

Article Text

Article menu
Download PDFPDF
Editorial commentaries
Using biomarkers to disentangle different causes of Parkinsonism
  1. Dag Aarsland1,2,3,
  2. Per Svenningsson1,2
  1. 1Department of Neurobiology, Ward and Society; Alzheimer's Disease Research Centre, Karolinska Institutet, Stockholm, Sweden
  2. 2Department of Neurology and Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
  3. 3Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway
  1. Correspondence to Dag Aarsland, Department of Neurobiology, Ward and Society; Alzheimer's Disease Research Centre, Karolinska Institutet, Novum, 141 86 Stockholm, Sweden; dag.aarsland{at}ki.se

https://doi.org/10.1136/jnnp-2012-303025

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Parkinsonism is a clinical motor syndrome characterised by tremor, rigidity, bradykinesia and postural instability and gait disturbance. Among the many causes, neurodegenerative diseases, such as Parkinson's disease (PD) and drug induced or vascular Parkinsonism (VP), are the most common.1 With the increasing number of elderly people, the prevalence of Parkinsonism is increasing. Accurate diagnosis of Parkinsonism is important for optimal management. Whereas much is known about the underlying mechanisms of PD, the mechanism and diagnostic markers of VP remain largely unknown. For example, it is unclear why the lower limbs are more commonly affected in VP when compared …

    View Full Text

    Footnotes

    • Competing interests DA has received research support from GE Health.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles